Institutional Ownership Brooklyn Immuno Therapeutics, Inc. (BTX)
This table provides information about the institutional ownership of Brooklyn Immuno Therapeutics, Inc. (BTX). We have compiled data on the 1 institutions that hold shares in the stock, with a total of 1.21 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Inverness Counsel LLC
|
Oct 26, 2022 Q3 2022 |
1,210,537
shares
|
$0
0.02% of portfolio
|
Q4 2021
Added 8786.63%
|